Also trades as: DMAQR (NASDAQ) · $vol 0M
DMAQ NASDAQ
Deep Medicine Acquisition Corp.
1W: -68.4%
1M: -74.6%
3M: -74.6%
1Y: -71.3%
$2.96
Last traded 2024-01-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$22M
+0.0% ▲
Gross Profit
$15M
+0.0% ▲
Operating Income
-$2M
+0.0% ▲
Net Income
-$9M
+0.0% ▲
EPS (Diluted)
$-0.76
+0.0% ▲
EBITDA
-$2M
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $22M |
| YoY Growth | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $60K | $60K | $7M |
| Gross Profit | -$60K | -$60K | $15M |
| Gross Margin | — | — | 66.7% |
| R&D Expenses | $0 | $0 | $0 |
| SG&A Expenses | $410K | $2M | $7M |
| Operating Expenses | $410K | $2M | $9M |
| Operating Income | -$462K | -$343K | -$2M |
| Operating Margin | — | — | -9.6% |
| Interest Expense | $8K | $0 | -$7M |
| Income Before Tax | -$414K | -$343K | -$9M |
| Tax Expense | -$56K | $58K | $0 |
| Net Income | -$358K | -$400K | -$9M |
| Net Margin | — | — | -40.2% |
| EPS (Diluted) | $-0.04 | $-0.04 | $-0.76 |
| EBITDA | -$350K | -$4M | -$2M |
| Shares Outstanding | 9M | 10M | 12M |